- Report
- August 2025
- 181 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1796EUR$2,000USD£1,534GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1347EUR$1,500USD£1,151GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2505EUR$2,789USD£2,140GBP
- Report
- May 2024
- 140 Pages
Global
From €4463EUR$4,969USD£3,812GBP
- Report
- May 2024
- 131 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- May 2024
- 140 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- May 2024
- 138 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- August 2022
- 113 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- May 2024
- 135 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- March 2025
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- January 2024
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- March 2026
- 150 Pages
Canada
From €4356EUR$4,850USD£3,721GBP
- Report
- March 2026
- 184 Pages
China
From €4356EUR$4,850USD£3,721GBP
- Report
- March 2026
- 252 Pages
India
From €4356EUR$4,850USD£3,721GBP
- Report
- August 2024
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- November 2025
- 290 Pages
Global
From €3974EUR$4,425USD£3,395GBP

Colony Stimulating Factor (CSF) is a type of drug used to treat immune disorders. It is a type of cytokine, a protein that helps regulate the immune system. CSF drugs are used to treat a variety of conditions, including neutropenia, anemia, and certain types of cancer. They can also be used to reduce the risk of infection in patients with weakened immune systems. CSF drugs work by stimulating the production of white blood cells, which help fight infection.
CSF drugs are typically administered intravenously or subcutaneously. Common side effects include fever, chills, nausea, and headache. In some cases, CSF drugs can cause allergic reactions or anaphylaxis.
The CSF market is a growing segment of the immune disorders drugs market. It is expected to continue to grow as more treatments become available and as the demand for immune-related treatments increases.
Some companies in the CSF market include Amgen, Biogen, Celgene, and Novartis. Show Less Read more